Alison Laws

6PUBLICATIONS
30CO-AUTHORS
Haematological tumoursOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Recommender systemsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 01, 2026
Active Surveillance for Atypical Ductal Hyperplasia: Are We Ready for Surgical De-escalation?

|Nov 07, 2024
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.

Giacomo Montagna, Alison Laws, Massimo Ferrucci

|May 01, 2023
Endocrine Therapy for Primary and Secondary Prevention After Diagnosis of High-Risk Breast Lesions or Preinvasive Breast Cancer.

Alison Laws, Rinaa S Punglia

|Oct 10, 2022
Development of an Electronic Health Record Registry to Facilitate Collection of Commission on Cancer Metrics for Patients Undergoing Surgery for Breast Cancer.

Heather G Lyu, Olga Kantor, Alison D Laws

|Nov 21, 2020
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer.

Ricardo G Pastorello, Alison Laws, Samantha Grossmith

|Oct 08, 2018
Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.

Alison Laws, Mantaj S Brar, Antoine Bouchard-Fortier

Pageof 1

Frequent Collaborators

2 joint publications

Tari A King

1 joint publications

Heather G Lyu

1 joint publications

Elizabeth A Mittendorf

1 joint publications

Ricardo G Pastorello